Cynomolgus Monkey as a Potential Model to Assess Drug Interactions Involving Hepatic Organic Anion Transporting Polypeptides: In Vitro, In Vivo, and In Vitro-to-In Vivo Extrapolation-Reference-Cited by-同舟云学术

Cynomolgus Monkey as a Potential Model to Assess Drug Interactions Involving Hepatic Organic Anion Transporting Polypeptides: In Vitro, In Vivo, and In Vitro-to-In Vivo Extrapolation

Published:2013-01-07 Issue:3 Volume:344 Page:673-685
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Shen Hong,Yang Zheng,Mintier Gabe,Han Yong-Hae,Chen Cliff,Balimane Praveen,Jemal Mohammed,Zhao Weiping,Zhang Renjie,Kallipatti Sanjith,Selvam Sabariya,Sukrutharaj Sunil,Krishnamurthy Prasad,Marathe Punit,Rodrigues A. David

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference43 articles.

1. Clinical pharmacokinetics of rifampicin;Acocella;Clin Pharmacokinet,1978

2. Pharmacokinetic studies on antituberculosis regimens in humans. I. Absorption and metabolism of the compounds used in the initial intensive phase of the short-course regimens: single administration study;Acocella;Am Rev Respir Dis,1985

3. A Comparison of Pharmacokinetics between Humans and Monkeys

4. Genome-based analysis of the nonhuman primate Macaca fascicularis as a model for drug safety assessment

5. The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Determinants of Daprodustat Drug–Drug Interactions and Pharmacokinetics in Hepatic Dysfunction and Chronic Kidney Disease: Significance of OATP1B‐CYP2C8 Interplay;Clinical Pharmacology & Therapeutics;2024-02-26

2. A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants;Journal of Pharmacology and Experimental Therapeutics;2024-01-31

3. Building a Predictive PBPK Model for Human OATP Substrates: a Strategic Framework for Early Evaluation of Clinical Pharmacokinetic Variations Using Pitavastatin as an Example;The AAPS Journal;2024-01-05

4. Generation of cynomolgus monkey airway, liver ductal, and kidney organoids with pharmacokinetic functions;Organs-on-a-Chip;2023-12

5. The fluorescence‐based competitive counterflow assay developed for organic anion transporting polypeptides 1A2, 1B1, 1B3 and 2B1 identifies pentamidine as a selective OATP1A2 substrate;The FASEB Journal;2023-10-02